(Source: Antares Pharma Inc) U.S. Patent Number 8,480,631 - Includes Product and Method of Use Claims EWING, NJ, June 27, 2013 - Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received a Notice of Issuance from the U. S. Patent Office for patent number 8,480,631 entitled "Hazardous Agent Injection System." The claims of this patent are directed toward an injection system for methotrexate and also a method for treating rheumatoid arthritis and other autoimmune diseases using an auto-injector or...
↧